Drug Topics e-News:
Having trouble viewing this email? View in a browser.
|
You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.
|
to Drug Topics e-News
|
|
|
|
 |
 |
| Newest: Creating an informational home pharmacy |
| For pharmacists, from Drug Topics: Continuing education for pharmacists and pharmacy technicians. Go to CE site here |
|
|
|
|
Survey
This month we would like to know...
In your practice setting, has the process for Risk Evaluation and Mitigation Strategies (REMS) implementation been automated?
• Yes, we are using an automated system.
• No, we are not yet using an automated system.
• No, but we plan to use an automated system in the next 6 months.
• No, but we plan to use an automated system in the next 12 months.
|
|
|
There is no safe therapeutic window of time for using NSAIDs in patients with prior myocardial infarction. Even short-term treatment with most NSAIDs appears associated with increased risk of death and recurrent MI, reported a study published in Circulation. Read full article. |
 |
|
|
To confirm your e-newsletter subscription, click here.
To ensure future delivery of email newsletters from
Drug Topics, please take a moment to confirm your subscription by clicking here.
Thank you,
Drug Topics Staff
|
 |
A monthly review of the
peer-reviewed literature by
Drug Topics' Editorial Advisor
Anna D. Garrett, PharmD, BCPS. Anna Garrett is manager, Outpatient Clinical Pharmacy Programs, Mission Hospital, Asheville, N.C.
|
Risk of VTE recurrence higher for patients with nonsurgical risk factors
Read full article.
|
Denosumab (Xgeva, Amgen) significantly increased bone metastasis-free survival for more than 4 months in men with castrate-resistant metastatic prostate cancer that had not yet spread to bone, according to results of a landmark study of Xgeva, presented at a late-breaking plenary session at the American Urological Association's 2011 annual meeting in Washington, D.C. Read full article. |
|
New competency reports for pharmacists and other healthcare professionals aim to set forth strategies that will help providers work together better. Read full article. |
|
Early commencement of oral antiretroviral therapy by men and women infected with HIV substantially reduced the risk that they would transmit the virus to their uninfected sexual partners, according to findings from a large multinational clinical study conducted by the HIV Prevention Trials Network. Read full article. |
|
|
Proton pump inhibitors are associated with a 29% increased risk of fracture, including a 31% increased risk of hip fracture and a 54% increased risk of vertebral fracture, according to a study published in the May/June 2011 issue of Annals of Family Medicine. Read full article.
|
|
Integrated television-based technology can help hospitals meet the patient-centeredness requirements of federal reform initiatives, stated a recent white paper released by LodgeNet Healthcare, a provider of media and connectivity solutions for hospitals.
Read full article.
|
|
The American Pharmacists Association is encouraging seniors to contact their pharmacists during Older Americans Month to gain better knowledge of the medications they are taking and to learn about available wellness opportunities.
Read full article.
 |
Meetings and Events
June 1-2, 2011 PQA Annual Meeting
Washington, D.C.
Contact:
Karen Peterson
9687 South Run Oaks Drive
Fairfax Station, VA 22039
Fax: 703-690-1756
kpeterson@pqaalliance.org
June 2-3 PQA/URAC Medication Adherence Summit
Washington, D.C.
Contact:
Jackie Green
1220 L Street NW, Suite 400
Washington, D.C. 20005
703-927-1599
jgreen@pqaalliance.org
June 3-5 NCPA Diabetes Accreditation Standards-Practical Applications (DASPA)
Brooklyn, NY
Contact:
100 Daingerfield Road
Alexandria, VA 22314
800-544-7447
July 22-25, 2011 NPhA Annual Convention
Atlanta
Contact:
107 Kilmayne Drive, Suite C
Cary, NC 27511
Phone: 404-262-3344
Fax: 404-262-8689
|
|
|
|
| Contact Us |
Contact a Drug Topics editor Click Here
Contact a Drug Topics sales representative Click Here
Learn about direct mail, reprints and classifieds in Drug Topics Click Here |
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
